Milena Živković | Artificial Intelligence in Medicine | Best Researcher Award

Posted on by sciencefather

Ms. Milena Živković | Artificial Intelligence in Medicine | Best Researcher Award

Research Associate| University of Kragujevac, Faculty of Science, Serbia

Milena Živković is a Research Associate at the University of Kragujevac, Faculty of Science, Serbia, with a background in physics and a research focus on the integration of artificial intelligence into medical physics and science education. Her expertise lies in AI-supported educational systems, Monte Carlo simulations in radiotherapy, and environmental radioactivity. With over 38 published papers, her work bridges physics, machine learning, and curriculum innovation. Milena is recognized for her mentorship of gifted students, contribution to interdisciplinary AI-based learning models, and international collaborations with researchers in Europe and the Middle East. She has co-authored dosimetric simulation software for cancer treatment optimization and earned accolades such as Best Oral Presentation Awards at international conferences. As an active member of the Serbian and German Physical Societies, she fosters science communication through national outreach projects and educational initiatives. Her contributions span both academic excellence and impactful community-based science promotion efforts.

Profile

🎓 Education

Milena Živković earned her formal education in physics, culminating in specialized research focused on medical physics, radiation dosimetry, and educational technology. She has completed advanced academic training in English for Academic Communication and Python programming, including Stanford’s “Code in Place.” She holds a Cambridge English Certificate and multiple certificates from the University of Kragujevac in academic writing and pedagogy. Her achievements during her student years include receiving the Annual Award for Best Student from 2015 to 2019, reflecting both academic excellence and extracurricular engagement. Additionally, she has participated in numerous interdisciplinary workshops, competitions, and science communication events, contributing to both her intellectual and pedagogical growth. With a strong foundation in applied physics, her academic journey has been characterized by the seamless integration of theoretical knowledge and practical research, which she continues to expand through post-academic training, conference participation, and interdisciplinary research collaboration with clinical and educational institutions.

🧪 Experience

Milena Živković has significant experience as a Research Associate at the University of Kragujevac, where she combines artificial intelligence with physics education and medical applications. Her research includes machine learning models for radiation dosimetry, classification systems in physics education, and anomaly detection in environmental radioactivity. She serves as a section editor and reviewer for journals like Imaging and Radiation Research and Radiation Science and Technology. Milena is also a contributor to national gifted education programs, curriculum development initiatives, and AI-assisted learning models. She has collaborated with international institutions, including projects with the Clinical Center Kragujevac and partners from Iraq, enhancing the practical application of her research. She has guided STEM projects for youth and mentored students in high school competitions. Her book on Monte Carlo simulations is used in academic and clinical contexts. Her scientific outreach projects further amplify her impact across the academic, educational, and public spheres.

🏅 Awards and Honors

Milena Živković has been the recipient of numerous awards recognizing both academic and community contributions. She received the Best Researcher Award at the University of Kragujevac in 2023 and multiple Best Oral Presentation Awards at international conferences in gynecology, women’s health, and ophthalmology. She also won the Bridge of Mathematics First Place Projects (2023, 2024), highlighting innovative physics education. From 2015 to 2019, she was honored with the Annual Best Student Award and continues to receive high praise for promoting science through projects funded by Serbia’s Center for the Promotion of Science. These include thematic campaigns like Brian May and the Queen of Physics, Our Air = Our Health, and Work + Active = Radioactive. Additionally, she holds advanced training certifications in pedagogy, communication, academic writing, and programming. Her dedication to science communication, youth mentorship, and educational innovation has made her a strong contender for the Young Scientist or Best Researcher Award.

🔬 Research Focus

Milena Živković’s research sits at the intersection of artificial intelligence, medical physics, and education technology. She focuses on developing machine learning-based models for radiation dose analysis, anomaly detection in environmental radioactivity, and AI-assisted problem classification in physics education. Her contributions to the FOTELP-VOX Monte Carlo platform enable precision 3D dose distribution modeling, now applied in clinical settings. She also investigates the ecological effects of radionuclide transfer and food safety. Milena’s interdisciplinary work includes collaborations with philosophers, clinicians, educators, and AI developers to improve curriculum delivery and treatment outcomes. She actively integrates AI into educational strategies to support gifted students and has co-authored software tools used in radiotherapy optimization. Her studies are not only technical but are aimed at real-world impact—ensuring safer radiation practices, informed public health strategies, and accessible science education. Her research promotes knowledge translation, making complex physics applicable to both education and healthcare.

✅ Conclusion

Milena Živković exemplifies a new generation of researchers merging artificial intelligence with applied physics to transform education, healthcare, and science communication. Through interdisciplinary projects, academic excellence, and outreach initiatives, she continues to redefine how science serves society while mentoring future innovators and advancing clinical safety and educational equity.

Publications

  • FOTELP-VOX-OA: Enhancing radiotherapy planning precision with particle transport simulations and Optimization Algorithms

    Computer Methods and Programs in Biomedicine
    2025-08 | Journal article
    DOI: 10.1016/j.cmpb.2025.108838
    CONTRIBUTORS: Milena Zivkovic; Filip Andric; Marina Svicevic; Dragana Krstic; Lazar Krstic; Bogdan Pirkovic; Tatjana Miladinovic; Mohamed El Amin Aichouche

  • FOTELP-VOX 2024: Comprehensive overview of its capabilities and applications

    Nuclear Technology and Radiation Protection
    2024 | Journal article
    DOI: 10.2298/NTRP2403212Z
    CONTRIBUTORS: Milena Zivkovic, P.; Tatjana Miladinovic, B.; Zeljko Cimbaljevic, M.; Mohamed Aichouche, E.A.; Bogdan Pirkovic, A.; Dragana Krstic, Z.

  • Radionuclide contamination in agricultural and urban ecosystems: A study of soil, plant, and milk samples

    Kragujevac Journal of Science
    2024 | Journal article
    DOI: 10.5937/KgJSci2400011A
    CONTRIBUTORS: Mohamed Aichouche, E.A.; Mihajlo Petrović, V.; Milena Živković, P.; Dragana Krstić, Ž.; Snežana Branković, R.

  • Development of DynamicMC for PHITS Monte Carlo package

    Radiation Protection Dosimetry
    2023-11-13 | Journal article
    DOI: 10.1093/rpd/ncad278
    Part of ISSN: 0144-8420
    Part of ISSN: 1742-3406
    CONTRIBUTORS: Hiroshi Watabe; Tatsuhiko Sato; Kwan Ngok Yu; Milena Zivkovic; Dragana Krstic; Dragoslav Nikezic; Kyeong Min Kim; Taiga Yamaya; Naoki Kawachi; Hiroki Tanaka et al.

Ali Osman | Life Science | Best Researcher Award

Posted on by sciencefather

Dr. Ali Osman | Life Science | Best Researcher Award

👨‍🔬 Prof. Ali Osman Mohamed Osman Khalil is a distinguished biochemist specializing in agricultural sciences. 🎓 He earned his PhD in Biochemistry from Zagazig University, Egypt, in 2012. 🏫 Currently, he serves as a Professor at the Biochemistry Department, Faculty of Agriculture, Zagazig University. 📚 With over 130 international publications and an impressive h-index of 33 (Google Scholar), his research has significantly impacted agricultural biochemistry. 🏅 He has received prestigious awards, including the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and First Class Scientific Franchise from the President (2017). 🌱 His research focuses on environmentally friendly bioproducts, plant disease control, and biochemical applications in agriculture. 🌍 He is an active member of international scientific societies and serves as an external reviewer for renowned journals. ✨ Prof. Khalil has also collaborated on major scientific projects, contributing to advancements in biochemistry and sustainable agriculture.

Profile

Education 🎓

📜 Prof. Khalil holds a PhD in Biochemistry (2012) from Zagazig University, Egypt, with excellence. 🏆 His academic journey started with a B.Sc. in Agricultural Sciences-Biochemistry (2004), followed by an M.Sc. in Biochemistry (2008), both earned with distinction. 🎯 His studies focused on the biochemical mechanisms in agriculture, leading to his expertise in plant sterols, post-harvest protection, and biochemical applications in food science. 🔬 He has undertaken international fellowships, including INRA-France (2007-2008) and Umeå University-Sweden (2023-2024), enriching his research in clinical microbiology, infection, and immunology. 🌍 His educational background has provided a strong foundation for his pioneering research in agricultural biochemistry and food technology.

Experience 👨‍🏫

🔬 Prof. Khalil has over 20 years of academic experience at Zagazig University, Egypt. 📚 He began as a Teaching Assistant (2004-2008), then progressed to Assistant Lecturer (2008-2012) and Lecturer (2012-2017). 🎓 His expertise led to his promotion as an Assistant Professor (2017-2022) and later Professor (2022-present) in Biochemistry. 🏛️ His teaching covers biochemical applications in agriculture, plant metabolism, and molecular biochemistry. 🏅 He has supervised numerous postgraduate students, fostering the next generation of scientists. 🔍 As a principal investigator and collaborator in several international projects, he has worked on plant disease control, bioproduct development, and oxidation mechanisms. 📑 His editorial contributions include reviewing for top journals like LWT-Food Science and Technology, International Dairy Journal, and the African Journal of Agricultural Research. 🌍 His extensive research and teaching experience have solidified his reputation as a leading expert in biochemistry.

Awards & Recognitions 🏅

🎖️ Prof. Khalil has received numerous awards for his outstanding contributions to biochemistry and agricultural sciences. 🏅 In 2017, he was honored with the First Class Scientific Franchise by the Egyptian President for his scientific achievements. 🏆 He won the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and the Zagazig University Prize for Encouragement in Agricultural Sciences (2017). 🍏 His research excellence was recognized with the George Steno Award for Best Applied Research in Pomology (2017). 🌍 His global impact in plant biochemistry is further demonstrated by his international fellowships at INRA-France (2007-2008) and Umeå University-Sweden (2023-2024). 💡 As a member of esteemed scientific societies, including the American Chemical Society and Egyptian Botanical Society, he actively contributes to advancing agricultural research. 📚 His accolades reflect his dedication to innovation, sustainability, and scientific excellence in biochemistry

Research Interests 🔬

🌿 Prof. Khalil’s research primarily revolves around biochemical applications in agriculture, including post-harvest disease control, plant metabolism, and sustainable bioproducts. 🧪 His h-index of 33 (Google Scholar) and 132 SCOPUS-indexed publications highlight his impactful work. 🔍 As the Principal Investigator of projects like “Fighting Plant Fungi Post-Harvest Using Environmentally Friendly Bioproducts”, he explores innovative solutions for agricultural sustainability. 🌱 His research extends to plant sterol oxidation, polymerization, and antiviral strategies for plant protection. 📊 His expertise in biochemical pathways and molecular interactions has led to the development of novel biochemical strategies to enhance crop productivity and food safety. 🌍 His international collaborations, including a Spanish-Egyptian research project on molecular modeling, further advance his contributions to biochemistry, plant pathology, and environmental sustainability. ✨ His work bridges biochemistry and agriculture, making significant strides toward sustainable farming solutions

4Publications 

1. Eskandrani, A. A., Alsubaie, N., Bawahab, A. A., Abd-Elhakim, Y. M., Ibrahim, R. E.,
Khamis, T., Osman, A,… & Mohamed, A. A. R. (2025). Whey protein hydrolysate from
camel mitigates hypoxia-induced renal and gill damage in Nile Tilapia: Effects on stress, HIFα, apoptosis, inflammation, and metabolic pathways. Aquaculture, 742256.
2. Alsubaie, N., Mohamed, A. A. R., Metwally, M. M., Khamis, T., Osman, A., Alotaibi, B. S.,
… & Ibrahim, R. E. (2025). Alkalinity exposure induced growth inhibition, intestinal
histopathological changes, and down-regulated nutrient transporter expression in Nile Tilapia:
The ameliorative role of dietary camel whey protein hydrolysates. Comparative Biochemistry
and Physiology Part B: Biochemistry and Molecular Biology, 111074.
3. Alsubaie, N., Ibrahim, R. E., Bawahab, A. A., Mohamed, A. A. R., Abd-Elhakim, Y. M.,
Khamis, T., Osman, A., … & Ghannam, H. E. (2025). Ameliorative role of camel protein
hydrolysates diet against alkaline stress in Oreochrmis niloticus: Hematology, immune
responses and their regulating genes expression, and histopathological assays. Veterinary
Research Communications, 49(2), 79.
4. Dahran, N., Alotaibi, B. S., Abd-Elhakim, Y. M., Ibrahim, R. E., Metwally, M. M., Khamis,
T.,El-Far, A., Osman, A., … & Mohamed, A. A. R. (2025). Effects of camel whey protein
hydrolysate on growth, nutrient metabolism, and tight junction protein gene expression in
Oreochromis niloticus under hypoxia stress. Aquaculture International, 33(2), 137.
5. Elsheikh, M., Osman, A., Edris, S., Dawam, W., Sitohy, M., & Sabeq, I. (2024). Soybean
Glycinin’s Antibacterial Properties Provide a Feasible Natural Alternative for Improving the
Overall Quality and Shelf-Life of Beef Steaks and Combating Foodborne Pathogens. Food
and Bioprocess Technology, 1-16.
6. Amer, S. A., Ibrahim, R. E., Younis, E. M., Abdel-Warith, A. W. A., Osman, A., Davies, S.
J., & Shakweer, M. S. (2025). Potential of using kidney bean (Phaseolus vulgaris L) protein
hydrolysate as a plant protein supplement in Nile tilapia (Oreochromis niloticus) diets: effects
on growth, hematology, histology, and blood biochemical parameters. Aquaculture
International, 33(1), 95.
7. Amer, S. A., Behairy, A., Moustafa, A. A., Eltanahy, A., Younis, E. M., Abdel-Warith, A. W.
A., Osman, A., … & Tolba, S. A. (2024). Effects of dietary Arthrospira platensis phycocyanin
on growth, fatty acid assessment of breast muscles, hematobiochemical, immunological
responses, and hepatic histomorphology in broiler chickens. Journal of Applied
Phycology, 36(6), 3367-3380.
8. Ibrahim, R. E., Elshopakey, G. E., Aly, M. Y., Abdelwarith, A. A., Younis, E. M., AbdElhakim, Y. M., Khamis, T., Osman, A., … & Mohamed, A. A. R. (2024). Camel whey
protein hydrolysate diet mitigates alkaline stress–induced biochemical disorders and restores
the target of rapamycin, MAPK pathway, and autophagy-related gene expression in Nile
tilapia. Aquaculture International, 32(7), 9911-9932.
9. Sitohy, M., Enan, G., Abdel-Shafi, S., El-Wafa, N. A., El-Gazzar, N., Osman, A., & Sitohy,
B. (2024). Mapping pathogenic bacteria resistance against common antibiotics and their
potential susceptibility to methylated white kidney bean protein. BMC microbiology, 24(1),
49.
10. Amer, S. A., Rahman, A. N. A., ElHady, M., Osman, A., Younis, E. M., Abdel-Warith, A.
W. A., … & Ibrahim, R. E. (2024). Use of moringa protein hydrolysate as a fishmeal replacer
in diet of Oreochromis niloticus: effects on growth, digestive enzymes, protein transporters
and immune status. Aquaculture, 579, 740202.
11. Imbabi, T. A., El‐Sayed, A. I., Radwan, A. A., Osman, A., & Abdel‐Samad, A. M. (2024).
Prevention of aflatoxin B1 toxicity by pomegranate peel extract and its effects on growth,
blood biochemical changes, oxidative stress and histopathological alterations. Journal of
Animal Physiology and Animal Nutrition, 108(1), 174-184.

PhongSon Dinh | Gene function analysis | Best Researcher Award

Posted on by sciencefather

Dr. PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. Dinh Phong Son is a prominent researcher at Duy Tan University, Vietnam, specializing in laboratory medicine and molecular medicine. With a PhD from Guangxi Medical University, China, he is dedicated to advancing the field of molecular biology and medical diagnostics. His work focuses on identifying biomarkers for early disease detection and investigating gene targets for targeted therapies. He actively contributes to scientific advancements in understanding complex diseases such as cancer, diabetes, and cardiovascular diseases. Through his expertise in molecular techniques like CRISPR/Cas9, PCR, and sequencing, Dr. Son plays a vital role in improving medical diagnostics and treatments. 🧬🔬

Profile

Education 🎓

Dr. Dinh Phong Son holds a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China, after earning his degree in Laboratory Medicine from Hue University of Medicine and Pharmacy, Vietnam. His educational background has equipped him with the expertise in molecular biology, enabling him to explore complex diseases at a molecular level and work on cutting-edge technologies in the field of gene editing and disease diagnosis. 🎓📚

Experience 👨‍🏫

Dr. Dinh Phong Son has significant experience in molecular medicine, focusing on the development of biomarkers for early disease diagnosis and treatment. With expertise in molecular biology techniques such as PCR, qPCR, CRISPR/Cas9, and sequencing, he has conducted extensive research on diseases like cancer, cardiovascular disorders, and diabetes. His work integrates bioinformatics and molecular assays to understand gene functions and identify potential drug targets. He is actively contributing to scientific publications and advancing the research community’s knowledge in disease diagnostics and therapies. 🔬💡

Research Interests 🔬

Dr. Dinh Phong Son’s research focuses on molecular techniques for disease detection and gene therapy. His current work includes exploring circRNA, miRNA, mRNA, and their role in diseases like coronary heart disease and cancer. Dr. Son is particularly interested in developing diagnostic biomarkers and therapeutic targets for systemic diseases using next-generation sequencing and CRISPR/Cas9. He also investigates the interaction networks between lncRNA, circRNA, miRNA, genes, and proteins, aiming to create molecular-based solutions for precision medicine. His research paves the way for future advancements in molecular diagnostics and personalized therapies. 🔬🧬

Awards & Recognitions 🏅

Dr. Dinh Phong Son’s contributions to molecular medicine have earned him recognition in the scientific community. His research publications, particularly on gene networks and biomarkers in cardiovascular and cancer research, have garnered widespread attention. He is currently a nominee for the Best Researcher Award, reflecting his ongoing commitment to advancing the fields of molecular biology, gene therapy, and disease diagnostics. His work is an important step toward improving public health outcomes through the application of molecular techniques. 🏆🏅

Publications 📚

  • Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

    Biochemistry and Biophysics Reports
    2025-03 | Journal article
    DOI: 10.1016/j.bbrep.2025.101952
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Hai-Anh Ha; Aigul Utegenova; Awais Ali; Abdulaziz Alamri

  • Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

    Journal of Biomolecular Structure and Dynamics
    2024-07-02 | Journal article
    DOI: 10.1080/07391102.2023.2225109
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Awais Ali; ShangLing Pan

  • Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

    Journal of Biomolecular Structure and Dynamics
    2024-03-15 | Journal article
    DOI: 10.1080/07391102.2024.2328744
    CONTRIBUTORS: ChauMyThanh Tran; PhongSon Dinh

  • Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease

    Frontiers in Cardiovascular Medicine
    2023-03-14 | Journal article
    DOI: 10.3389/fcvm.2023.1104223
    Part of ISSN: 2297-055X
    CONTRIBUTORS: PhongSon Dinh; JunHua Peng; ThanhLoan Tran; DongFeng Wu; ChauMyThanh Tran; ThiPhuongHoai Dinh; ShangLing Pan

Fan Zhang | Proteomics | Best Researcher Award

Posted on by sciencefather

Dr. Fan Zhang | Proteomics | Best Researcher Award

Fan Zhang, born on September 23, 1991, is a postdoctoral researcher specializing in cancer proteogenomics 🔬. He is currently with the Department of Pathology at Duke University 🏛️. His research leverages mass spectrometry and bioinformatics 🖥️ to investigate metabolic pathways in therapy-resistant prostate cancer and other malignancies. He has received the FY23 Prostate Cancer Research Program Early Investigator Research Award 🏆 for his work on glutamine metabolism in advanced prostate cancer. His contributions to proteogenomics have resulted in multiple high-impact publications 📄 in Nature Communications, Cell Research, and Molecular & Cellular Proteomics. Proficient in LC-MS/MS, bioinformatics analysis, and experimental techniques, his research bridges the gap between basic cancer biology and clinical applications 🏥, paving the way for novel therapeutic strategies in oncology.

Profile

Education 🎓

Fan Zhang holds a Ph.D. in Biochemistry and Molecular Biology from Fudan University (2015-2020), where he focused on proteogenomic research. He further pursued postdoctoral training in Clinical Medicine at Fudan University (2020-2022) before joining Duke University as a postdoctoral researcher in the Department of Pathology in 2023. His academic journey began with a B.S. in Applied Biological Science from Anhui Agricultural University (2011-2015). Throughout his education, he gained expertise in genomics, transcriptomics, and proteomics, developing a strong foundation in bioinformatics and experimental methodologies. His interdisciplinary training has equipped him with skills in mass spectrometry-based proteomics, omics data analysis, and cancer metabolism research. His current research at Duke University focuses on metabolic vulnerabilities in prostate cancer, aiming to develop targeted therapies. His diverse academic background enables him to integrate various scientific disciplines, contributing significantly to cancer research and precision medicine.

Experience 👨‍🏫

Fan Zhang has extensive research experience in cancer proteogenomics. Currently a postdoctoral researcher at Duke University (2023-present), he investigates metabolic vulnerabilities in prostate cancer using advanced mass spectrometry and omics analysis. Previously, he was a postdoc in Clinical Medicine at Fudan University (2020-2022), where he contributed to proteogenomic studies on various cancers, including pituitary neuroendocrine tumors and diffuse large B-cell lymphoma. His Ph.D. at Fudan University (2015-2020) focused on proteogenomic characterizations of cancer, leading to high-impact publications. He is proficient in LC-MS/MS, bioinformatics, and experimental methodologies such as Western blotting, immunofluorescence, and cell culture. His research integrates mass spectrometry with genomics and transcriptomics to uncover novel therapeutic targets. With expertise in multi-omics data analysis, he has significantly contributed to the field of cancer biology. His work is supported by prestigious grants, highlighting his role as a leading researcher in proteogenomics and precision oncology.

Research Interests 🔬

Fan Zhang’s research focuses on proteogenomics and cancer metabolism, particularly in therapy-resistant malignancies like prostate cancer, pituitary neuroendocrine tumors, and diffuse large B-cell lymphoma. He specializes in mass spectrometry-based proteomics (DDA, DIA) and integrates multi-omics approaches, including genomics, transcriptomics, and metabolomics, to uncover novel cancer vulnerabilities. His current work at Duke University investigates glutamine metabolism in castration-resistant prostate cancer, aiming to develop targeted therapies. His expertise extends to bioinformatics analysis, large-cohort omics data interpretation, and advanced LC-MS/MS techniques for various biological samples. His research has led to multiple high-impact publications, highlighting his ability to translate complex molecular data into potential clinical applications. By combining experimental and computational approaches, he aims to identify biomarkers and therapeutic targets that can improve cancer treatment. His contributions to proteogenomics play a crucial role in advancing precision oncology and understanding the metabolic reprogramming of aggressive cancers.

 

Awards & Recognitions 🏅

Fan Zhang has received multiple awards and recognitions for his contributions to cancer proteogenomics. He was awarded the Fiscal Year 2023 (FY23) Prostate Cancer Research Program (PCRP) Early Investigator Research Award (2023-2025) for his project on targeting glutamine metabolism in advanced prostate cancer (Award Number HT9425-24-1-0237). His research has been recognized through multiple first-author and co-first-author publications in high-impact journals such as Nature Communications, Molecular & Cellular Proteomics, Cell Research, and The Prostate. His work has also been featured as a cover article in Cell Research (2022). His expertise in mass spectrometry, proteogenomics, and bioinformatics has positioned him as a leading young investigator in the field. In addition to research grants, he has received accolades for his innovative contributions to metabolic studies in oncology. His commitment to advancing cancer research has been instrumental in developing novel therapeutic strategies for therapy-resistant malignancies.

Publications 📚

Shilpa Kumari | Biotechnology | Best Researcher Award

Posted on by sciencefather

Ms.Shilpa Kumari | Biotechnology | Best Researcher Award

 

Sharda University, India

Profile

Education

She is currently pursuing a Ph.D. at Sharda University since 2020, having completed her coursework with an impressive 84.5%. She holds an M.Sc. in Biotechnology from Chandigarh University, where she secured 79.6% in 2019. Prior to that, she earned her B.Sc. from HNB Garhwal Central University, Srinagar, in 2017 with a score of 66.7%. She completed her 12th grade in the Medical stream under CBSE in 2014 with 74.4% and her 10th grade in General Science in 2012, securing 75.5%.

 

Awards

She has been awarded the Sharda University Research Scholarship (SURS) by Sharda University since February 2021. She received a Silver Medal at the 8th Annual Meeting of the International Association of Zoologists and the 5th International Conference on Recent Trends in Life Sciences and Biotechnology held at Maharishi Markandeshwar (Deemed to be University), Haryana, in December 2024. Additionally, she was granted International Travel Support from the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, to present her research at the University Malay, Kuala Terengganu, Malaysia, in August 2024. She secured 2nd Prize at the Anveshan International Convention 2023-2024 (North Zone), organized by the Association of Indian Universities (AIU) in January 2024. Furthermore, she won the Best Oral Presentation Award at the National Conference on Disease Diagnosis and Drug Development Against Human Pathogens, sponsored by DBT and organized by Muthyammal College of Arts and Science in November 2023.

Book chapters

1. Shilpa Kumari, Neha Verma, Anil Kumar, Sunita Dalal, and Kanu Priya. “Functional
overrepresentation analysis and their application in microbial pathogenesis.” In Systems Biology
Approaches for Host-Pathogen Interaction Analysis, pp. 171-179. Academic Press, 2024.
2. Neha Verma, Shilpa Kumari, Anil Kumar, and Kanu Priya. “Advancements in systems biologybased analysis of microbial pathogenesis.” In Systems Biology Approaches for Host-Pathogen
Interaction Analysis, pp. 181-190. Academic Press, 2024

Publication

Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

Posted on by sciencefather

Mr. Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

PhD Scholar at Acharya and BM Reddy College of Pharmacy, Bengaluru, India

Mr. Rohit Pal is a dedicated and emerging researcher in the field of pharmaceutical sciences, particularly focusing on drug discovery and development. Currently pursuing his Ph.D. at Acharya & BM Reddy College of Pharmacy in Bengaluru, he is engaged in innovative research on Pyrimidine derivatives as fourth-generation EGFR inhibitors to combat Non-Small Cell Lung Cancer (NSCLC). With a strong academic background, including an M.Pharmacy in Pharmaceutical Chemistry, Mr. Pal combines his expertise in chemical synthesis with cutting-edge computational techniques like molecular docking and structure-activity relationship (SAR) analysis. His work spans multiple research areas, including anticonvulsant activity, anti-inflammatory research, and the pharmacognostic standardization of endangered species like Passiflora vitifolia. Throughout his career, Mr. Pal has demonstrated a capacity for both in-silico drug design and experimental testing, balancing theoretical approaches with hands-on experimentation. His impressive publication record in respected journals further showcases his capability to contribute to the scientific community. As a promising young researcher, Mr. Pal’s ongoing work not only advances pharmaceutical sciences but also holds potential for meaningful clinical applications in cancer therapy and drug design.

Profile

Orcid

 

Education 🎓

Mr. Rohit Pal’s educational background demonstrates a consistent pursuit of excellence in the field of pharmaceutical sciences. He is currently enrolled in a Ph.D. program at Acharya & BM Reddy College of Pharmacy in Bengaluru, Karnataka, where his research is focused on the development of Pyrimidine derivatives as EGFR inhibitors to target Non-Small Cell Lung Cancer (NSCLC). Prior to his doctoral studies, Mr. Pal completed his M.Pharmacy in Pharmaceutical Chemistry from ISF College of Pharmacy in Moga, Punjab, achieving a notable CGPA of 9.07. His academic journey began with a B. Pharmacy from Dev Bhoomi Institute of Pharmacy and Research, Dehradun, where he gained a robust foundation in pharmaceutical sciences. Additionally, Mr. Pal holds a D. Pharmacy from SGGS College of Pharmacy, Chandigarh, further demonstrating his dedication to the field from the onset of his academic career. His varied educational experiences have shaped his interdisciplinary approach to pharmaceutical research, combining knowledge from chemistry, biology, and computational sciences. This solid academic foundation has propelled Mr. Pal to explore complex drug development challenges, particularly in cancer therapy, with a keen interest in molecular-level drug interactions.

Work Experience 💼

Mr. Rohit Pal’s professional experience reflects a promising trajectory in pharmaceutical research and drug discovery. As a Ph.D. scholar at Acharya & BM Reddy College of Pharmacy, he is deeply involved in researching Pyrimidine derivatives for EGFR inhibition in Non-Small Cell Lung Cancer (NSCLC). His research explores the design, synthesis, and evaluation of novel drug candidates, combining in-vitro testing with computational drug design. Through the use of molecular docking and structure-activity relationship (SAR) analysis, Mr. Pal aims to identify compounds with high therapeutic potential. Beyond his Ph.D. work, Mr. Pal has worked on various other research projects, including 1,2,4-triazine derivatives for anticonvulsant activity and the anti-inflammatory properties of Passiflora vitifolia, an endangered plant species. His work spans both synthetic chemistry and biological testing, allowing him to gain expertise in pharmacological assays and computational modeling. Mr. Pal’s professional experience also includes using sophisticated instruments such as HPLC, UV spectrophotometers, and Microwave Synthesizers, which complement his experimental work and ensure the reliability of his results. These experiences have positioned him well for future leadership roles in pharmaceutical research and drug developmen

Awards and Honors

Although still in the early stages of his academic career, Mr. Rohit Pal has already garnered significant recognition for his research efforts. His academic excellence is reflected in his M.Pharmacy CGPA of 9.07, placing him among the top students in his cohort. Mr. Pal’s research has been published in reputable journals such as the Journal of Biomolecular Structure and Dynamics and Chemical Physics Impact, demonstrating the impact and quality of his work. These publications are indicative of his ability to produce research that contributes to the scientific community. Despite being early in his career, his involvement in cutting-edge research on Pyrimidine derivatives and EGFR inhibitors has already gained attention within the academic and pharmaceutical fields. His dedication to molecular docking, drug design, and pharmacognostic studies positions him for further recognition. As Mr. Pal continues to contribute to innovative drug development solutions, he is likely to receive more prestigious awards and honors, reflecting the growing importance of his work in cancer research and pharmaceutical chemistry.

Research Interests

Mr. Rohit Pal’s research interests are centered around the intersection of pharmaceutical chemistry and drug discovery. His primary focus is on developing Pyrimidine derivatives as fourth-generation EGFR inhibitors aimed at Non-Small Cell Lung Cancer (NSCLC), a serious health concern with limited therapeutic options. By targeting the epidermal growth factor receptor (EGFR), his work could offer more effective treatment alternatives for cancer patients. In addition to cancer research, Mr. Pal has explored 1,2,4-triazine derivatives for evaluating anticonvulsant activity, contributing to neurological disorder treatments. He is also interested in anti-inflammatory research, with a particular focus on Passiflora vitifolia, an endangered plant species, aiming to standardize its pharmacognostic properties. His multidisciplinary approach extends to the application of computational drug design, where he utilizes molecular docking and molecular dynamics simulations to predict drug-receptor interactions. Mr. Pal is committed to advancing drug development by combining experimental chemistry with in-silico methodologies, offering innovative solutions for complex healthcare challenges. His work on drug repurposing, targeted therapies, and sustainable drug sourcing reflects his holistic approach to addressing both scientific and global health concerns.

Research Skills

Mr. Rohit Pal possesses a wide range of research skills essential for successful pharmaceutical research. His proficiency in chemical synthesis includes techniques such as recrystallization, sublimation, and flash chromatography, which he applies to purify and isolate new compounds for testing. In addition to these laboratory techniques, Mr. Pal is highly skilled in analytical methods, including HPLC and UV spectrophotometry, to assess the purity and chemical composition of compounds. He is also adept at utilizing computational tools for drug design, particularly AutoDock, Biovia Drug Discovery Studio, and Pymol, to perform molecular docking and molecular dynamics simulations. These tools allow him to predict the interactions between drug candidates and their targets, enhancing the efficiency of drug development. Furthermore, Mr. Pal has experience in in-vitro biological testing, including assays for anticonvulsant, anti-inflammatory, and antioxidant activities, ensuring the biological relevance of his synthesized compounds. His ability to combine experimental techniques with computational modeling equips him to approach drug discovery from both theoretical and practical angles, ensuring well-rounded and impactful research outcomes.

📚 Publications

  • Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration
    • Journal: Journal of Molecular Structure
    • DOI: 10.1016/j.molstruc.2024.141227
    • Date: April 2025
    • Contributors: Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Ghanshyam Teli; Viney Chawla; Pooja A. Chawla
  • Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.117034
    • Date: January 2025
    • Contributors: Ebna Azizal Omar; Rajesh R.; Pronoy Kanti Das; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Lalmohan Maji
  • Benzothiazole a privileged scaffold for cutting-edge anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.116831
    • Date: December 2024
    • Contributors: Aayishamma I; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Abhishek Ghara; Nimmagadda Venkata Satya Sai Aishwarya; Kumaraswamy B; Ketan R. Hosamani; Manjushree B V; Haripriya E
  • An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
    • Journal: Journal of Biomolecular Structure and Dynamics
    • DOI: 10.1080/07391102.2023.2252082
    • Date: December 11, 2024
    • Contributors: Rohit Pal; Ghanshyam Teli; Sindhuja Sengupta; Lalmohan Maji; Gurubasavaraja Swamy Purawarga Matada
  • Exploring the anticancer potential of triazine derivatives: An outlook of designing strategies, docking studies, and structure-activity relationships (SAR)
    • Journal: ChemistrySelect
    • DOI: 10.1002/slct.202402766
    • Date: November 2024
    • Contributors: B. V. Manjushree; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Md. Ashadul Sk; M. P. Viji; Nimmagadda Venkata Satya Sai Aishwarya; Pronoy Kanti Das; I. Aayishamma; S. Mounika
  • Pyrazole, pyrazoline, and fused pyrazole derivatives: New horizons in EGFR-targeted anticancer agents
    • Journal: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202400880
    • Date: November 2024
    • Contributors: Ketan R Hosamani; Hemalatha K; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Kumaraswamy B; Aayishamma I; Nimmagadda Venkata Satya Sai Aishwarya

Conclusion 

Mr. Rohit Pal is an exceptionally talented and promising researcher in the field of pharmaceutical sciences. His research, focused on Pyrimidine derivatives as EGFR inhibitors for Non-Small Cell Lung Cancer (NSCLC), is not only innovative but holds significant promise for advancing cancer treatment. His combination of chemical synthesis, computational drug design, and biological testing reflects his multidisciplinary approach to pharmaceutical research. Mr. Pal’s commitment to anti-inflammatory, anticonvulsant, and pharmacognostic standardization further demonstrates his versatility as a researcher. While still in the early stages of his career, his publication record and expertise in molecular docking and drug design suggest that he is well on his way to becoming a leader in pharmaceutical research. His ongoing work could contribute to groundbreaking advancements in cancer therapy, neurological disorder treatments, and sustainable drug sourcing. With his strong educational background, solid professional experience, and growing body of work, Mr. Rohit Pal is undoubtedly a candidate with the potential to make meaningful contributions to drug development and global health. His future in research looks bright, and he is well-positioned for recognition in upcoming awards such as the Young Scientist Award.